WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to fac ...

WESTPORT, Conn., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Altor Solutions ("Altor"), a subsidiary of Compass Diversified (NYSE: CODI) and a leading designer and manufacturer of custom protective and coldchain packaging solutions for the industrial and life sciences markets, today announced it has entered into a definitive agreement to acquire Lifoam Industries, LLC ("Lifoam"), a manufacturer and distributor of temperature-controlled shipping solutions, for an enterprise value of $137 million in cash at closing (ex ...

NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) ("Compass" or "the Company"), the largest residential real estate company in the United States by sales volume[1], announces that its CEO & Founder Robert Reffkin will participate in Oppenheimer's 27th Annual Technology, Internet & Communications Conference. The virtual event is scheduled for Tuesday, August 13, 2024. Compass Chief Financial Officer Kalani Reelitz and Chief Accounting Officer Scott Wahlers will join Reffkin. Reffkin and the t ...

BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Wedbush PacGrow Healthcare Conference taking place in New York City, New York on Tuesday, August 13, 2024, at 11 AM ET. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical ...

Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression expected in fourth quarter 2024 Gino Santini to join Board of Directors as Chairman Lori Englebert named new Chief Commercial Officer Cash position of $228.6 million Conference call August 1 at 8:00 am ET (1:00 pm UK) LONDON and NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental he ...

Compass, Inc. (COMP) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 300%. A quarter ago, it was expected that this company would post a loss of $0.20 per share when it actually produced a loss of $0.27, delivering a surprise of -35%. Over the last four quarters, the company has surpasse ...

WESTPORT, Conn., July 31, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today its consolidated operating results for the three months ended June 30, 2024. "I'm pleased to announce another strong quarter with results that exceeded our expectations, driven by continued strength in our consumer businesses," said Elias Sabo, CEO of Compass Diversified. "While Q2 saw deteriorating economic conditions that negatively im ...

All-Time High Net Income of $20.7 million All-Time High Adjusted EBITDA of $77.4 million Free Cash Flow Positive for 4 of the Last 5 Quarters Increased Quarterly Market Share to 5.13% NEW YORK, July 31, 2024 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) ("Compass" or "the Company"), the largest residential real estate brokerage in the United States by sales volume1 for the third year in a row, announced its financial results for the second quarter ended June 30, 2024. "In light of a quarter where the real esta ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Compass, Inc. (COMP) reports results for the quarter ended June 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On ...

Thank you. And our final question comes from Joe Thomas of HSBC. Your line is open. Please go ahead. Joe Thomas Hi. Good morning. Three questions, if you wouldnÂ't mind, please. Firstly, I think you mentioned that you were talking about new business mobilization in Q4. And I think the implication was that there might have been a bit of a drag on margin in Q4. Could you just clarify whether that is the case and what the scale of that drag might be? And then related to that, the usual question, any update on ...